BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

866 related articles for article (PubMed ID: 19356483)

  • 21. MRI monitoring of myocardial iron overload: use of cardiac MRI combined with hepatic MRI in a cohort of multi-transfused patients with thalassaemia.
    Quatre A; Jacquier A; Petit P; Giorgi R; Thuret I
    Diagn Interv Imaging; 2014 Nov; 95(11):1065-9. PubMed ID: 25001363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
    Kolnagou A; Yazman D; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):312-22. PubMed ID: 19814677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
    Said Othman KM; Elshazly SA; Heiba NM
    Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study.
    Casale M; Meloni A; Filosa A; Cuccia L; Caruso V; Palazzi G; Gamberini MR; Pitrolo L; Putti MC; D'Ascola DG; Casini T; Quarta A; Maggio A; Neri MG; Positano V; Salvatori C; Toia P; Valeri G; Midiri M; Pepe A
    Circ Cardiovasc Imaging; 2015 Aug; 8(8):e003230. PubMed ID: 26253625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of iron overload with T2* magnetic resonance imaging.
    Anderson LJ
    Prog Cardiovasc Dis; 2011; 54(3):287-94. PubMed ID: 22014495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between myocardial T2 values and cardiac volumetric and functional parameters in β-thalassemia patients evaluated by cardiac magnetic resonance in association with serum ferritin levels.
    Liguori C; Pitocco F; Di Giampietro I; de Vivo AE; Schena E; Cianciulli P; Zobel BB
    Eur J Radiol; 2013 Sep; 82(9):e441-7. PubMed ID: 23639773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between color M-mode echocardiography flow propagation and cardiac iron load on MRI in patients with thalassemia major.
    Ozbek O; Acar K; Kayrak M; Ozbek S; Gül EE; Uçar R; Paksoy Y
    Diagn Interv Radiol; 2012; 18(2):208-14. PubMed ID: 22006577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of left ventricular and atrial diastolic function using two-dimensional (2D) strain imaging in patients with β-thalassemia major.
    Karamanou AG; Hamodraka ES; Vrakas SC; Paraskevaidis I; Lekakis I; Kremastinos DT
    Eur J Haematol; 2014 Jan; 92(1):59-65. PubMed ID: 24118422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure.
    Pennell DJ; Carpenter JP; Roughton M; Cabantchik Z
    J Cardiovasc Magn Reson; 2011 Sep; 13(1):45. PubMed ID: 21910880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between T2* cardiovascular magnetic resonance with left ventricular function and mass in adolescent and adult major thalassemia patients with iron overload.
    Djer MM; Anggriawan SL; Gatot D; Amalia P; Sastroasmoro S; Widjaja P
    Acta Med Indones; 2013 Oct; 45(4):295-301. PubMed ID: 24448334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peak Filling Rates Assessed by CMR Imaging Indicate Diastolic Dysfunction From Myocardial Iron Toxicity.
    Schoennagel BP; Fischer R; Grosse R; Berliner C; Wehbe M; Kurio G; Lund G; Wang ZJ; Graessner J; Adam G; Yamamura J
    JACC Cardiovasc Imaging; 2016 Nov; 9(11):1353-1354. PubMed ID: 26777217
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of CMR feature-tracking derived left ventricular strain in predicting myocardial iron overload and assessing myocardial contractile dysfunction in patients with thalassemia major.
    Ojha V; Ganga KP; Seth T; Roy A; Naik N; Jagia P; Gulati GS; Kumar S; Sharma S
    Eur Radiol; 2021 Aug; 31(8):6184-6192. PubMed ID: 33721061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction.
    Kasner M; Westermann D; Lopez B; Gaub R; Escher F; Kühl U; Schultheiss HP; Tschöpe C
    J Am Coll Cardiol; 2011 Feb; 57(8):977-85. PubMed ID: 21329845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.
    Tanner MA; Galanello R; Dessi C; Smith GC; Westwood MA; Agus A; Roughton M; Assomull R; Nair SV; Walker JM; Pennell DJ
    Circulation; 2007 Apr; 115(14):1876-84. PubMed ID: 17372174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased sympathovagal imbalance evaluated by heart rate variability is associated with decreased T2* MRI and left ventricular function in transfusion-dependent thalassemia patients.
    Pattanakuhar S; Phrommintikul A; Tantiworawit A; Konginn S; Srichairattanakool S; Chattipakorn SC; Chattipakorn N
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29330222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.
    Nabati M; Janbabai G; Baghyari S; Esmaili K; Yazdani J
    J Cardiovasc Pharmacol; 2017 May; 69(5):279-285. PubMed ID: 28141699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of iron overload on exercise capacity in thalassemic patients with heart failure.
    Mavrogeni S; Gotsis E; Verganelakis D; Berdousis E; Dritsas A; Kolovou G; Toulas P; Ladis V
    Int J Cardiovasc Imaging; 2009 Dec; 25(8):777-83. PubMed ID: 19680779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between NT-proBNP levels, iron overload, and early stage of myocardial dysfunction in β-thalassemia major patients.
    Balkan C; Tuluce SY; Basol G; Tuluce K; Ay Y; Karapinar DY; Gurgun C; Bayindir O; Kavakli K
    Echocardiography; 2012 Mar; 29(3):318-25. PubMed ID: 22066516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging during management of patients with transfusion-dependent thalassemia: a single-center experience.
    Karakas Z; Yilmaz Y; Bayramoglu Z; Karaman S; Aydogdu S; Karagenc AO; Tugcu D; Dursun M
    Radiol Med; 2018 Aug; 123(8):572-576. PubMed ID: 29663188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.